Each 2.5 ml ampoule contains:
Salbutamol (as salbutamol sulfate) 2.5mg
Ipratropium bromide 0.5mg

Solution for Nebuliser

The management of bronchospasm in patients suffering from chronic obstructive pulmonary disease who require regular treatment with both ipratropium and salbutamol.

The recommended dose is: 1 single dose unit three or four times daily.

Instructions for use

The unit dose vials are intended only for inhalation with suitable nebulising devices and should not be taken orally or administered parenterally.

The content of the unit dose vials does not need to be diluted for nebulization.

Prepare the nebuliser for filling, according to the instruction provided by the manufacturer or doctor.
Open the pouch foil and tear one unit dose vial from the strip
Open the unit dose vial by firmly twisting the top
Squeeze the content of the unit dose vial into the nebuliser reservoir
Assemble the nebuliser and use as directed
After use throw away any solution left in the reservoir and clean the nebuliser, following the manufacturer's instructions
Since the single dose units contain no preservatives, it is important that the contents are used immediately after opening and that a fresh vial is used for each administration to avoid microbial contamination. Partly used, open or damaged single dose units should be discarded.

It is strongly recommended not to mix ZENCOMBI with other drugs in the same nebuliser.